Related references
Note: Only part of the references are listed.Drug metabolic stability in early drug discovery to develop potential lead compounds
Siva Nageswara Rao Gajula et al.
DRUG METABOLISM REVIEWS (2021)
In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and development
Chuang Lu et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2020)
Metabolite Profiling and Reaction Phenotyping for the in Vitro Assessment of the Bioactivation of Bromfenac
Aprajita S. Yadav et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Computational prediction of cytochrome P450 inhibition and induction
Harutoshi Kato
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Electrochemical oxidation of estrogens as a method for CYP19A1 (aromatase) electrocatalytic activity determination
Alexey V. Kuzikov et al.
ELECTROCHIMICA ACTA (2020)
All-electrochemical nanocomposite two-electrode setup for quantification of drugs and study of their electrocatalytical conversion by cytochromes P450
Victoria V. Shumyantseva et al.
ELECTROCHIMICA ACTA (2020)
Quasi-Irreversible Inhibition of CYP2D6 by Berberine
Ha Gyeong Kim et al.
PHARMACEUTICS (2020)
Pharmacokinetic drug-drug interactions: an insight into recent US FDA-approved drugs for prostate cancer
Siva Nageswara Rao Gajula et al.
BIOANALYSIS (2020)
Computational methods and tools to predict cytochrome P450 metabolism for drug discovery
Jonathan D. Tyzack et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Bioelectrochemical Systems as Technologies for Studying Drug Interactions Related to Cytochrome P450
Victoria V. Shumyantseva et al.
BIONANOSCIENCE (2019)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
WhichP450: a multi-class categorical model to predict the major metabolising CYP450 isoform for a compound
Peter A. Hunt et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
Application of in vitro CYP and transporter assays to predict clinical drug-drug interactions
Donna A. Volpe et al.
BIOANALYSIS (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Assembly of Hepatocyte Spheroids Using Magnetic 3D Cell Culture for CYP450 Inhibition/Induction
Pujan K. Desai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools
Naiem T. Issa et al.
CURRENT DRUG METABOLISM (2017)
Bioelectrochemistry as a tool for the study of aromatization of steroids by human aromatase
Giovanna Di Nardo et al.
ELECTROCHEMISTRY COMMUNICATIONS (2015)
Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4
Chunhuan Jin et al.
XENOBIOTICA (2015)
Electrocatalytic cycle of P450 cytochromes: the protective and stimulating roles of antioxidants
V. V. Shumyantseva et al.
RSC ADVANCES (2015)
Cytochrome P450 (CYP) enzymes and the development of CYP biosensors
Elizabeth Schneider et al.
BIOSENSORS & BIOELECTRONICS (2013)
Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment
Frank Z. Stanczyk et al.
CONTRACEPTION (2013)
Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs
Koichi Ueno et al.
HYPERTENSION RESEARCH (2012)
Breakthrough in P450 bioelectrochemistry and future perspectives
Sheila J. Sadeghi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development
David O. Nettleton et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Novel advances in cytochrome P450 research
Deepika Singh et al.
DRUG DISCOVERY TODAY (2011)
An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes
Andrew Parkinson et al.
DRUG METABOLISM AND DISPOSITION (2011)
CYP2D plays a major role in berberine metabolism in liver of mice and humans
Ying Guo et al.
XENOBIOTICA (2011)
Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass spectrometry and tandem mass spectrometry): Where is the crossover point?
A. Kaufmann et al.
ANALYTICA CHIMICA ACTA (2010)
An Electrochemical Microfluidic Platform for Human P450 Drug Metabolism Profiling
Andrea Fantuzzi et al.
ANALYTICAL CHEMISTRY (2010)
A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s
Kuresh A. Youdim et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4
Howard J. Burt et al.
XENOBIOTICA (2010)
Ion Trap Array Mass Analyzer: Structure and Performance
Xiaoxu Li et al.
ANALYTICAL CHEMISTRY (2009)
Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions
Rowan A. Stringer et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott W. Grimm et al.
DRUG METABOLISM AND DISPOSITION (2009)
In vitro evaluation of reversible and irreversible cytochrome P450 inhibition:: Current status on methodologies and their utility for predicting drug-drug interactions
Stephen Fowler et al.
AAPS JOURNAL (2008)
Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism
Thomas A. Baillie
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities
Jose de Leon et al.
CLINICS IN LABORATORY MEDICINE (2008)
Cytochrome P450 turnover: Regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2008)
Clinical Utility of Microarrays: Current Status, Existing Challenges and Future Outlook
Xinmin Li et al.
CURRENT GENOMICS (2008)
The conduct of drug metabolism studies considered good practice (II):: In vitro experiments
Lee Jia et al.
CURRENT DRUG METABOLISM (2007)
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment
K. Venkatakrishnan et al.
XENOBIOTICA (2007)
The evolving role of drug metabolism in drug discovery and development
Lilian G. Yengi et al.
PHARMACEUTICAL RESEARCH (2007)
An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates
Dieter M. Drexler et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Time-dependent CYP inhibition
Robert J. Riley et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2007)
Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes
Jiang-Wei Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
F Ghanbari et al.
CURRENT DRUG METABOLISM (2006)
The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
RS Obach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Prediction of in vivo drug-drug interactions from in vitro data - Factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4
Hayley S. Brown et al.
CLINICAL PHARMACOKINETICS (2006)
Prediction of in vivo drug-drug interactions from in vitro data:: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant
HS Brown et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
High throughput P450 inhibition screens in early drug discovery
G Zlokarnik et al.
DRUG DISCOVERY TODAY (2005)
Kinetic values for mechanism-based enzyme inhibition: Assessing the bias introduced by the conventional experimental protocol
JS Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Automated assessment of time-dependent inhibition of human cytochrome P450 enzymes using liquid chromatography-tandem mass spectrometry analysis
A Atkinson et al.
DRUG METABOLISM AND DISPOSITION (2005)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Cytochrome P450 enzymes mechanism based inhibitors: Common sub-structures and reactivity
E Fontana et al.
CURRENT DRUG METABOLISM (2005)
In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: Prediction of nonstationary pharmacokinetics and drug interaction magnitude
K Venkatakrishnan et al.
DRUG METABOLISM AND DISPOSITION (2005)
Prediction of drug metabolism and interactions on the basis of in vitro investigations
O Pelkonen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism
JH Ansede et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
MS Faber et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Drug-drug interactions for UDP-glucuronosyltransferase substrates:: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2004)
Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
TD Bjornsson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: Implications for relating in vitro inhibition data to in vivo drug interactions
JM Margolis et al.
DRUG METABOLISM AND DISPOSITION (2003)
Genomic medicine - Inheritance and drug response.
R Weinshilboum
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Reaction phenotyping in drug discovery: Moving forward with confidence?
JA Williams et al.
CURRENT DRUG METABOLISM (2003)
Cytochrome P450 pharmacogenetics in drug development:: In vitro studies and clinical consequences
AD Rodrigues et al.
CURRENT DRUG METABOLISM (2002)
Mechanism-based inactivation of cytochrome P450 3A4 by 17α-ethynylestradiol:: Evidence for heme destruction and covalent binding to protein
HL Lin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes
N Hanioka et al.
DRUG METABOLISM AND DISPOSITION (2002)
Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models
K Venkatakrishnan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Role of drug metabolism in drug discovery and development
GN Kumar et al.
MEDICINAL RESEARCH REVIEWS (2001)
High-throughput screening approaches for investigating drug metabolism and pharmacokinetics
SA Roberts
XENOBIOTICA (2001)
Screening of drug candidates for their drug-drug interaction potential
AD Rodrigues et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Share Paper
